0001213900-23-067446.txt : 20230815 0001213900-23-067446.hdr.sgml : 20230815 20230815080017 ACCESSION NUMBER: 0001213900-23-067446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230815 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisman Harlan F CENTRAL INDEX KEY: 0001555563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 231173243 MAIL ADDRESS: STREET 1: C/O CORONADO BIOSCIENCES, INC. STREET 2: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2023-08-15 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001555563 Weisman Harlan F 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 1 1 0 0 President and CEO 0 Common Stock 2023-08-15 4 P 0 600000 0.25 A 814615 D Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023. /s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact 2023-08-15